Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Anifrolumab, Anifrolumab Placebo
AstraZeneca AB
Polymyositis or dermatomyositis according to 2017 EULAR / ACR classification criteria
1 trial -
Anodal tDCS
United Therapeutics Europe Ltd
Stroke
1 trial -
Anterior Capsulotomy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obsessive-Compulsive Disorder
1 trial -
Anti C5 Complement mAb Placebo, Ultomiris 1,100 mg/11 mL concentrate for solution for infusion
Alexion Europe SAS
Immunoglobulin A Nephropathy (IgAN)
1 trial -
Anti C5 Complement mAb Placebo, Ultomiris 300 mg/30 mL concentrate for solution for infusion
Alexion Europe SAS
Hematopoietic stem cell transplant-associated thrombotic microangiopathy
1 trial -
Anti-thymocyte globulin
Ultragenyx UK Limited
Aplastic Anemia
1 trial -
Antidepressant + SPD489 (Lisdexamfetamine dimesylate) 10 mg
Takeda
Major Depressive Disorder
3 trials -
Antihemophilic Factor Manufactured and Formulated without Added Human or Animal Proteins (rAHF-PFM)
Takeda
Hemophilia A
1 trial -
Antiplatelet (Aspirin, Dipyridamole, clopidogrel)
United Therapeutics Europe Ltd
Cervical Artery Dissection
1 trial -
Apalutamide
Janssen Cilag International NV
Metastatic Castrate-sensitive Prostate Cancer
1 trial -
Apitox, purified honeybee toxin, lyophilized in saline
Apimeds Pharmaceuticals US
Osteoarthritis of the Knee
1 trial -
Apixaban
United Therapeutics Europe Ltd
Cerebral Vein Thrombosis
2 trials -
Apremilast, Apremilast, Apremilast
Amgen
BehΓ§etβs disease is a chronic, relapsing, multisystem inflammatory disorder of unknown etiology characterized by 4 major symptoms (oral aphthous ulcers, genital ulcers, skin lesions, and ocular lesions) and occasionally by 5 minor symptoms (arthritis, gastrointestinal ulcers, epididymitis, vascular lesions, and central nervous system [CNS] symptoms) (Cho, 2012). Juvenile idiopathic arthritis is a heterogeneous group of chronic inflammatory disorders that initially presents in children by the age of 16 years. It refers to arthritis of at least 6 weeks duration of unknown etiology that begins in children less than 16 years old. Juvenile idiopathic arthritis has an annual incidence of 2 to 20 cases per 100 000 population and a prevalence of 16 to 150 cases per 100 000 population. It is an autoimmune disorder marked by abnormalities of immune responses (Adelowo, 2010).
1 trial -
Aramchol free acid
Galmed Pharmaceuticals
Nonalcoholic Steatohepatitis (NASH)
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted), Comirnaty Omicron XBB.1.5 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
GlaxoSmithKline
Respiratory Syncytial Virus Infections
1 trial -
Aripiprazole
Otsuka Beijing Research Institute
Bipolar I
1 trial -
Aripiprazole IM Depot
Otsuka Beijing Research Institute
Schizophrenia
1 trial -
Arm A Mylotarg plus DA Versus CPX-351
Cardiff Oncology
Acute Myeloid Leukaemia
1 trial -
Armodafinil
Teva Pharma GmbH
Depression
4 trials -
Armodafinil
Teva Pharma GmbH
Traumatic Brain Injury
2 trials -
Armodafinil
Teva Pharma GmbH
Excessive Daytime Sleepiness
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources